Indication

Severe recalcitrant nodular rosacea

Severe recalcitrant nodular rosacea is an advanced, treatment-resistant dermatologic presentation of chronic rosacea, most commonly affecting the central facial skin of adults. Read more about Severe recalcitrant nodular rosacea

13 drugs 11 manufacturers

Advertisement

Drugs that treat it

Common Severe recalcitrant nodular rosacea therapies.

Showing 1–9 of 13 drugs

Filter & compare in the drug finder →Opens the drug finder with Severe recalcitrant nodular rosacea preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Severe recalcitrant nodular rosacea.

Severe recalcitrant nodular rosacea is an advanced, treatment-resistant dermatologic presentation of chronic rosacea, most commonly affecting the central facial skin of adults.

It is characterized by persistent erythema and the formation of deep-seated, tender inflammatory nodules and plaques that fail to respond adequately to standard topical therapies or conventional oral antimicrobial regimens.

Pathophysiologically, it involves dysregulated innate immunity, neurovascular hyperactivity, and pronounced dermal infiltrate often exhibiting granulomatous inflammation centered around pilosebaceous units.

If left unmanaged, the severe ongoing inflammation can lead to progressive dermal fibrosis, significant facial lymphedema, and secondary tissue scarring.

Personalize your experience

Follow Severe recalcitrant nodular rosacea and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it